greeksoup/ stock research
Stock research / United States / KRSA / 13F holders

Korsana Biosciences, Inc. 13F holders

None of the 44 funds followed here reported a position in Korsana Biosciences, Inc. in its latest 13F.

Schedule 13D and 13G filed on the name, last twelve months

FiledScheduleWhoHoldingOf the classEvent dateRule or purposeFiling
15 October 202613G/AJ. Wood Capital Advisors LLC and 3 others25,9740.1%30 September 2026passive, under 20% (13d-1(c))EDGAR
7 October 202613G/AFMR LLC and 3 others3.1 million6.9%30 September 2026passive, institutional (13d-1(b))EDGAR
18 September 202613GGeneral Atlantic, L.P. and 33 others3.2 million6.8%8 September 2026passive, other (13d-1(d))EDGAR
16 September 202613GWellington Biomedical Innovation Master Investors (Cayman) II, L.P. and 1 other2.8 million6.1%9 September 2026passive, under 20% (13d-1(c))EDGAR
15 September 202613DVenrock Healthcare Capital Partners III, L.P. and 8 others4.6 million9.9%8 September 2026The Reporting Persons purchased the aforementioned securities for investment purposes with the aim of increasing the value of their investments and the Issuer. Subject to applicable legal requirements, one or more of the Reporting Persons mEDGAR
11 September 202613DFairmount Funds Management LLC and 4 others9.1 million20.0%8 September 2026The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company's aggregate outstanding shares as of September 8, 2026. The Reporting Persons' securities include (a) 2,691 shares of Common Stock issuable upon the exEDGAR
14 August 202613GBalyasny Asset Management L.P. and 9 others317,5117.3%30 June 2026passive, institutional (13d-1(b))EDGAR
14 August 202613GADAR1 Capital Management, LLC and 3 others298,7577.0%30 June 2026passive, institutional (13d-1(b))EDGAR
20 July 202613D/APeter M. Hecht910,24019.4%16 July 2026EDGAR
7 May 202613GFMR LLC and 3 others649,54715.0%30 April 2026passive, institutional (13d-1(b))EDGAR
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read moreAmendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13G

Fails to deliver

No share in Korsana Biosciences, Inc. failed to deliver at settlement on any day in the SEC's last three half-month files.